142 related articles for article (PubMed ID: 12516988)
1. Using inverse-weighting in cost-effectiveness analysis with censored data.
Willan AR; Lin DY; Cook RJ; Chen EB
Stat Methods Med Res; 2002 Dec; 11(6):539-51. PubMed ID: 12516988
[TBL] [Abstract][Full Text] [Related]
2. Incremental net benefit in randomized clinical trials with quality-adjusted survival.
Willan AR; Chen EB; Cook RJ; Lin DY
Stat Med; 2003 Feb; 22(3):353-62. PubMed ID: 12529868
[TBL] [Abstract][Full Text] [Related]
3. Regression methods for cost-effectiveness analysis with censored data.
Willan AR; Lin DY; Manca A
Stat Med; 2005 Jan; 24(1):131-45. PubMed ID: 15515137
[TBL] [Abstract][Full Text] [Related]
4. Bayesian estimation of cost-effectiveness from censored data.
Heitjan DF; Kim CY; Li H
Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
[TBL] [Abstract][Full Text] [Related]
5. Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data.
Wang H; Zhao H
Biometrics; 2006 Jun; 62(2):570-5. PubMed ID: 16918922
[TBL] [Abstract][Full Text] [Related]
6. Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored data.
Pullenayegum EM; Willan AR
Stat Med; 2007 Jul; 26(17):3274-99. PubMed ID: 17309112
[TBL] [Abstract][Full Text] [Related]
7. Incremental net benefit in randomized clinical trials.
Willan AR; Lin DY
Stat Med; 2001 Jun; 20(11):1563-74. PubMed ID: 11391688
[TBL] [Abstract][Full Text] [Related]
8. Net-benefit regression with censored cost-effectiveness data from randomized or observational studies.
Chen S; Hoch JS
Stat Med; 2022 Sep; 41(20):3958-3974. PubMed ID: 35665527
[TBL] [Abstract][Full Text] [Related]
9. On estimating medical cost and incremental cost-effectiveness ratios with censored data.
Zhao H; Tian L
Biometrics; 2001 Dec; 57(4):1002-8. PubMed ID: 11764238
[TBL] [Abstract][Full Text] [Related]
10. A two-part model for censored medical cost data.
Tian L; Huang J
Stat Med; 2007 Oct; 26(23):4273-92. PubMed ID: 17330248
[TBL] [Abstract][Full Text] [Related]
11. Estimating incremental cost-effectiveness ratios and their confidence intervals with different terminating events for survival time and costs.
Chen S; Zhao H
Biostatistics; 2013 Jul; 14(3):422-32. PubMed ID: 23426525
[TBL] [Abstract][Full Text] [Related]
12. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data.
Willan AR; Briggs AH; Hoch JS
Health Econ; 2004 May; 13(5):461-75. PubMed ID: 15127426
[TBL] [Abstract][Full Text] [Related]
13. Bias and precision of measures of survival gain from right-censored data.
Lamb KE; Williamson EJ; Coory M; Carlin JB
Pharm Stat; 2015; 14(5):409-17. PubMed ID: 26218830
[TBL] [Abstract][Full Text] [Related]
14. Estimating mean total costs in the presence of censoring: a comparative assessment of methods.
Young TA
Pharmacoeconomics; 2005; 23(12):1229-42. PubMed ID: 16336017
[TBL] [Abstract][Full Text] [Related]
15. Nonparametric inference for median costs with censored data.
Zhao H; Zuo C; Chen S; Bang H
Biometrics; 2012 Sep; 68(3):717-25. PubMed ID: 22364557
[TBL] [Abstract][Full Text] [Related]
16. Using propensity scores to estimate the cost-effectiveness of medical therapies.
Indurkhya A; Mitra N; Schrag D
Stat Med; 2006 May; 25(9):1561-76. PubMed ID: 16158412
[TBL] [Abstract][Full Text] [Related]
17. Estimating lifetime or episode-of-illness costs under censoring.
Basu A; Manning WG
Health Econ; 2010 Sep; 19(9):1010-28. PubMed ID: 20665908
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis with censored data.
Huang Y
Med Care; 2009 Jul; 47(7 Suppl 1):S115-9. PubMed ID: 19536024
[TBL] [Abstract][Full Text] [Related]
19. Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.
Oostenbrink JB; Rutten-van Mölken MP; Monz BU; FitzGerald JM
Value Health; 2005; 8(1):32-46. PubMed ID: 15841892
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).
Reynolds MR; Magnuson EA; Wang K; Lei Y; Vilain K; Walczak J; Kodali SK; Lasala JM; O'Neill WW; Davidson CJ; Smith CR; Leon MB; Cohen DJ;
Circulation; 2012 Mar; 125(9):1102-9. PubMed ID: 22308299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
